欧洲共识:慢性肾脏病成人与儿童的推荐钙摄入量
欧洲肾脏协会(ERA)与欧洲儿童肾脏病学会(ESPN)工作组制定共识,提出CKD成人与儿童钙管理的关键证据点和临床实践点,经Delphi专家组评审。建议成人CKD患者从饮食和药物摄入的总钙量为800-1000 mg/天且不超过1500 mg/天,以维持中性钙平衡;儿童CKD患者总钙摄入应保持在年龄对应的正常范围。这些声明提供信息并可能辅助决策,但在缺乏高级别证据时须仔细考虑并个体化调整。
要点
- 成人CKD患者建议总钙摄入(饮食+药物)800-1000 mg/天,不超过1500 mg/天。
- 儿童CKD患者总钙摄入应保持在年龄对应的正常范围。
- 声明基于证据但缺乏高级别证据,须个体化考虑。
核心结论
- 建议成人CKD患者总钙摄入800-1000 mg/天且不超过1500 mg/天以维持中性钙平衡。
- 儿童CKD患者总钙摄入应保持在年龄对应的正常范围。
- 这些声明在缺乏高级别证据时须仔细考虑并适应个体患者需求。
研究设计与样本
- 由ERA的CKD-MBD和欧洲肾脏营养工作组与ESPN的CKD-MBD和透析工作组制定关键证据点和临床实践点。
- 经ERA和ESPN工作组成员组成的Delphi专家组评审。
主要发现
- CKD患者矿物质和骨异常(MBD)常见,增加发病率和死亡率。
- 近几十年来一线控制甲状旁腺功能亢进的方法为外源性钙负荷,但血管钙化风险意识促使管理转变,减少使用含钙磷结合剂。
- 当代CKD患者可能存在负钙平衡,损害骨骼健康,导致肾性骨病和骨折风险增加。
- 钙摄入低于一定阈值可能与高摄入一样有问题,加重CKD的MBD综合征,但当前临床实践指南未涉及。
关键数值与推荐
- 成人CKD患者建议从饮食和药物摄入的总钙量为800-1000 mg/天,不超过1500 mg/天。
- 儿童CKD患者总钙摄入应保持在年龄对应的正常范围。
临床怎么用
- 临床决策中可参考上述钙摄入建议,但须结合个体患者需求仔细考虑和调整。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mineral and bone disorders (MBD) are common in patients with chronic kidney disease (CKD), contributing to significant morbidity and mortality. For several decades, the first-line approach to controlling hyperparathyroidism in CKD was by exogenous calcium loading. Since the turn of the millennium, however, a growing awareness of vascular calcification risk has led to a paradigm shift in management and a move away from calcium-based phosphate binders. As a consequence, contemporary CKD patients may be at risk of a negative calcium balance, which, in turn, may compromise bone health, contributing to renal bone disease and increased fracture risk. A calcium intake below a certain threshold may be as problematic as a high intake, worsening the MBD syndrome of CKD, but is not addressed in current clinical practice guidelines. The CKD-MBD and European Renal Nutrition working groups of the European Renal Association (ERA), together with the CKD-MBD and Dialysis working groups of the European Society for Pediatric Nephrology (ESPN), developed key evidence points and clinical practice points on calcium management in children and adults with CKD across stages of disease. These were reviewed by a Delphi panel consisting of ERA and ESPN working groups members. The main clinical practice points include a suggested total calcium intake from diet and medications of 800-1000 mg/day and not exceeding 1500 mg/day to maintain a neutral calcium balance in adults with CKD. In children with CKD, total calcium intake should be kept within the age-appropriate normal range. These statements provide information and may assist in decision-making, but in the absence of high-level evidence must be carefully considered and adapted to individual patient needs.
引用
- Evenepoel P, Jørgensen HS, Bover J, et al. Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement. Nephrol Dial Transplant. 2024. PMID: 37697718. doi:10.1093/ndt/gfad185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。